OTHER INFORMATION.
+Added: Not applicable
The exhibits filed or furnished as part of this Quarterly Report on Form 10-Q are set forth on the Exhibit Index, which Exhibit Index is incorporated herein by reference.
4 unchanged sentences
(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)
−Removed: November 10, 2022
EXHIBIT INDEX
8 unchanged sentences
Certificate of Amendment to Articles of Incorporation (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed February 16, 2012, File No.
−Removed: Certificate of Amendment to Certificate of Incorporation.
−Removed: (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed May 18, 2015, File No.
−Removed: Certificate of Amendment to Certificate of Incorporation.
−Removed: (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed September 8, 2017, File No.
+Added: Certificate of Amendment to Articles of Incorporation (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed May 18, 2015, File No.
+Added: Certificate of Amendment to Articles of Incorporation (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed September 8, 2017, File No.
Certificate of Designations for Series A Preferred Stock to Certificate of Incorporation (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed September 12, 2017, File No.
5 unchanged sentences
Certificate of Amendment to the Certificate of Designation for the Series A Convertible Preferred Stock (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K/A filed on February 1, 2021 File No.
−Removed: Certificate of Change Pursuant to NRS 78.
−Removed: -209 (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed July 25, 2022, File No.
−Removed: Form of Certificate of Designation of Series C Convertible Preferred Stock (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed July 29, 2022, File No.
−Removed: Form of Certificate of Designation of Series D Convertible Preferred Stock (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed July 29, 2022, File No.
−Removed: Certificate of Amendment to Articles of Incorporation (Incorporated by reference to Exhibit 3.1 of the Registrant’s Current Report on Form 8-K filed October 12, 2022, File No.
−Removed: Certificate of Change to Articles of Incorporation (Incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K filed October 12, 2022, File No.
−Removed: Amended and Restated By-laws (Incorporated by reference to Exhibit 3.3 of the Registrant’s Current Report on Form 8-K filed October 12, 2022, File No.
−Removed: Amendment No.
−Removed: 1 to the 2020 Stock Incentive Plan (Incorporated by reference to Appendix C to the Registrant’s Definitive Proxy Statement on Schedule 14A filed August 16, 2022, File No.
−Removed: Securities Purchase Agreement between Theriva Biologics Inc.
−Removed: and MSD Credit Opportunity Master Fund, L.P., dated as of July 28, 2022(Incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed July 29, 2022, File No.
−Removed: Amendment No.
−Removed: 1 dated as of August 9, 2022 to Securities Purchase Agreement between Theriva Biologics Inc.
−Removed: and MSD Credit Opportunity Master Fund, L.P., dated as of July 28, 2022 (Incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-Q filed August 11, 2022, File No.
+Added: Separation Agreement dated as of May 8, 2023 between Theriva Biologics, Inc.
+Added: and Frank Tufaro
+Added: Consulting Agreement dated as of May 8, 2023 between Theriva Biologics, Inc.
+Added: and Frank Tufaro
Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a)/15d-14(a)*
10 unchanged sentences
+ Management contract or compensatory plan or arrangement required to be identified pursuant to Item 15(a)(3) of this report.
+Added: †† Registrant has omitted certain portions of this exhibit in accordance with Item 601 (b)(10) of Regulation S-K.
+Added: The Company agrees to furnish unredacted copies of these exhibits to the SEC upon request
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.